Picture of Verastem logo

VSTM — Verastem News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Verastem Inc expected to post a loss of 74 cents a share - Earnings Preview

Verastem Inc VSTM.OQ VSTM.O is expected to  show a fall in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The Needham Massachusetts-based  company is expected to report a 88.8% decrease in revenue to $1.122 million from $10 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Verastem Inc is for a loss of 74 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 0.5% in the last three months. ‚Äč

Wall Street's median 12-month price target for Verastem Inc is $14.00, about 57.1% above its last closing price of $6.01

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDINGSTARMINESMARTESTIMATE¬ģLSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.69-0.71-0.79Missed-11.1
Dec. 31 2025-0.68-0.81-1.33Missed-64.7
Sep. 30 2024-0.70-0.74-0.60Beat18.7‚Äč
Jun. 30 2024-0.93-0.95-0.31Beat67.5
‚Äč‚ÄčMar. 31 2024-1.03-1.00-1.26Missed-26.4
Dec. 31 2023-0.74-0.62-1.02Missed-64.5‚Äč
Sep. 30 2023-0.87-0.84-0.75Beat11
Jun. 30 2023-1.07-1.06-1.37Missed-29.2
This summary was machine generated August 5 at 21:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Verastem

See all news